Related references
Note: Only part of the references are listed.Diosgenin induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma cells
Yongjian Li et al.
ONCOLOGY REPORTS (2015)
Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus
Tony N. Marion et al.
SEMINARS IN IMMUNOPATHOLOGY (2014)
Ginsenoside Rh1 potentiates dexamethasone's anti-inflammatory effects for chronic inflammatory disease by reversing dexamethasone-induced resistance
Jun Li et al.
ARTHRITIS RESEARCH & THERAPY (2014)
A novel NF-κB inhibitor, DHMEQ, ameliorates pristane-induced lupus in mice
Huiqing Qu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Electroacupuncture at Feishu (BL13) and Zusanli (ST36) down-regulates the expression of orexins and their receptors in rats with chronic obstructive pulmonary disease
Xin-Fang Zhang et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2014)
The use of glucocorticoids in Systemic Lupus Erythematosus. After 60 years still more an art than science
Remco K. M. A. C. Luijten et al.
AUTOIMMUNITY REVIEWS (2013)
Cutaneous lupus erythematosus: clinical aspects and molecular pathogenesis
V. Oke et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Anti-dsDNA Antibody Isotypes in Systemic Lupus Erythematosus: IgA in Addition to IgG Anti-dsDNA Help to Identify Glomerulonephritis and Active Disease
Danilo Villalta et al.
PLOS ONE (2013)
Antineoplastic effects of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber, on lung adenocarcinoma (A549) cells
Farha A. Kabeer et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2013)
Ginsenoside Rb1 inhibits osteoclastogenesis by modulating NF-κB and MAPKs pathways
Binbin Cheng et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity
H. Hanaoka et al.
LUPUS (2012)
Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia
Andrea Geiss et al.
PSYCHONEUROENDOCRINOLOGY (2012)
Ginsenoside Rg1, a Novel Glucocorticoid Receptor Agonist of Plant Origin, Maintains Glucocorticoid Efficacy with Reduced Side Effects
Juan Du et al.
JOURNAL OF IMMUNOLOGY (2011)
Mechanisms of B cell autoimmunity in SLE
Thomas Doerner et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Role of Nuclear Steroid Receptors in Apoptosis
Joana Amaral et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Upregulation Effect of Ginsenosides on Glucocorticoid Receptor in Rat Liver
C. Binbin et al.
HORMONE AND METABOLIC RESEARCH (2009)
Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus
Juan Du et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Glucocorticoid sensitivity in fibromyalgia patients: Decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper
Joana A. Macedo et al.
PSYCHONEUROENDOCRINOLOGY (2008)
Antinuclear antibodies measured by enzyme immunoassay in patients with systemic lupus erythematosus: relation to disease activity
Ehud Paz et al.
RHEUMATOLOGY INTERNATIONAL (2007)
C5a receptor deficiency attenuates T cell function and renal disease in MRL1pr mice
SE Wenderfer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Ginsenosides may reverse the dexamethasone-induced down-regulation of glucocorticold receptor
CQ Ling et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2005)
Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia
WJE Tissing et al.
LEUKEMIA (2003)
Decreased IL-4 producing CD4+ T cells in patients with active systemic lupus erythematosus-relation to IL-12R expression
K Sugimoto et al.
AUTOIMMUNITY (2002)
Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines
SK Agarwal et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Increased interferon-gamma (IFN-γ), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)
A Csiszár et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
